Cited by 191Tuberculosis Research and EpidemiologyInfectious Diseases and TuberculosisDiagnosis and treatment of tuberculosis

The DOI matches its Crossref record; 84 of the 85 references it cites were found in a registry or an index.

Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities

Open access

Abstract

Tuberculosis is unique among the major infectious diseases in that it lacks accurate rapid point-of-care diagnostic tests. Failure to control the spread of tuberculosis is largely due to our inability to detect and treat all infectious cases of pulmonary tuberculosis in a timely fashion, allowing continued Mycobacterium tuberculosis transmission within communities. Currently recommended gold-standard diagnostic tests for tuberculosis are laboratory based, and multiple investigations may be necessary over a period of weeks or months before a diagnosis is made. Several new diagnostic tests have recently become available for detecting active tuberculosis disease, screening for latent M. tuberculosis infection, and identifying drug-resistant strains of M. tuberculosis. However, progress toward a robust point-of-care test has been limited, and novel biomarker discovery remains challenging. In the absence of effective prevention strategies, high rates of early case detection and subsequent cure are required for global tuberculosis control. Early case detection is dependent on test accuracy, accessibility, cost, and complexity, but also depends on the political will and funder investment to deliver optimal, sustainable care to those worst affected by the tuberculosis and human immunodeficiency virus epidemics. This review highlights unanswered questions, challenges, recent advances, unresolved operational and technical issues, needs, and opportunities related to tuberculosis diagnostics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/jir860

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 85 references

Research works printed but not linked: 10

  1. World Health Organization, 2011, WHO report. Global tuberculosis control
  2. World Health Organization, 2010, Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response
  3. World Health Organization, 2011, Commercial serodiagnostic tests for diagnosis of tuberculosis: policy statement
  4. European Centre for Disease Prevention and Control, 2011, Use of interferon-gamma release assays in support of tuberculosis diagnosis
  5. World Health Organization, 2010, Use of interferon-γ release assays (IGRAs) in TB control in low and middle-income settings
  6. World Health Organization, 2011, Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational “How-to”; practical considerations
  7. 2011, FIND. Performance of Xpert MTB/RIF version G4 assay. Geneva: Foundation for Innovative New Diagnostics
  8. World Health Organization, 2008, New laboratory diagnostic tools for tuberculosis control
  9. World Health Organization, 2009, Report of the 9th meeting: WHO strategic and technical advisory group for tuberculosis
  10. Treatment Action Group, 2009, 2009 report on tuberculosis research funding Trends, 2005–2008

Cited by

Sorted by citations

Metadata

Authors
McNerney, R., Maeurer, M., Abubakar, I., Marais, B., Mchugh, T. D., Ford, N., Weyer, K., Lawn, S., Grobusch, M. P., Memish, Z., Squire, S. B., Pantaleo, G., Chakaya, J., Casenghi, M., Migliori, G.-B., Mwaba, P., Zijenah, L., Hoelscher, M., Cox, H., Swaminathan, S., Kim, P. S., Schito, M., Harari, A., Bates, M., Schwank, S., O’Grady, J., Pletschette, M., Ditui, L., Atun, R., & Zumla, A.
Affiliations
  • London School of Hygiene & Tropical Medicine (GB)
  • Karolinska Institutet (SE)
  • University of East Anglia (GB)
  • The University of Sydney (AU)
  • University College London (GB)
  • Médecins Sans Frontières (ZA)
  • World Health Organization (CH)
  • University of Cape Town (ZA)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Alfaisal University (SA)
  • Liverpool School of Tropical Medicine (GB)
  • Centre Hospitalier Universitaire Vaudois (CH)
  • Kenya Medical Research Institute (KE)
  • Ministry of Health (ZM)
  • University of Zimbabwe (ZW)
  • National Institute of Research in Tuberculosis (IN)
  • National Institutes of Health (US)
  • Henry M. Jackson Foundation (US)
  • University of Zambia (ZM)
  • European Commission (BE)
  • Global Fund to Fight AIDS, Tuberculosis and Malaria (CH)
Corresponding author
McNerney, Ruth
Venue
The Journal of Infectious Diseases
Published
2012-05-15
Volume
205
Issue
suppl_2
Pages
S147-S158
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2145481449
Cited by
191
References
85
Citations by year
2026: 4 · 2025: 12 · 2024: 4 · 2023: 8 · 2022: 9 · 2021: 9 · 2020: 5 · 2019: 12 · 2018: 7 · 2017: 13 · 2016: 16 · 2015: 23 · 2014: 21 · 2013: 36 · 2012: 12
FWCI
3.67
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • The Journal of Infectious Diseases (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • SERVAL (Université de Lausanne) (publishedVersion, other-oa)
  • NIRT Institutional Scholarship Repository (National Institute of Research in Tuberculosis) (acceptedVersion)
  • reroDoc Digital Library (submittedVersion)
  • IRIS (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • LSTM Online Archive (Liverpool School of Tropical Medicine) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Medecins Sans Frontieres Field Research (Medecins Sans Frontieres) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
Funders
  • University College London
  • UBS Optimus Foundation
  • University College London Hospitals NHS Foundation Trust
  • Medical Research Council
  • European and Developing Countries Clinical Trials Partnership
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
  • Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
Keywords
tuberculosis diagnosis, Mycobacterium tuberculosis, biomarkers, point-of-care testing, latent tuberculosis infection, drug-resistant tuberculosis, early case detection, tuberculosis control
MeSH terms
Antitubercular Agents, Bacteriological Techniques, Humans, Tuberculosis, Biomarkers, Drug Resistance, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review